School of Medicine
Showing 421-440 of 446 Results
-
Lu Yang
Instructor, Pathology
BioPhysician-scientist with broad interests in genetics/genomics, cell biology, developmental biology, cancer, clinical pathology, bioinformatics, and computer vision.
-
Ellen Yeh
Associate Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsThe chemistry and biology of the unusual plastid organelle, the apicoplast, in malaria parasites
-
Jingru Yu
Postdoctoral Scholar, Pathology
BioJingru Yu, PhD, MPH, is a postdoctoral researcher at the Department of Pathology. She is interested in developing early diagnostic tools for brain tumors and other solid tumors using epigenomic data and aims to improve the diagnosis and prognosis of tumors.
-
Muharrem Yunce, M.D.
Clinical Assistant Professor, Pathology
BioDr. Yunce is board certified in internal medicine and transfusion medicine. He joined Stanford Health Care as a clinical fellow and completed his fellowship in July 2019. He has keen interest in patient blood management and applications of therapeutic apheresis in various disease processes.
-
James L. Zehnder, M.D.
Professor of Pathology (Research) and of Medicine (Hematology)
Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.
-
Bing Melody Zhang
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main research interests lie in the following areas:
1) Using genetic/genomic approaches to study the genotype-phenotype correlation of inherited non-malignant hematologic disorders, especially platelet disorders.
2) Development and application of molecular assays for clinical testing to support hematopoietic stem cell transplantation and solid organ transplantation.
3) NGS-based TCR/Ig clonality/MRD diagnostic testing.
4) HLA-related disease association and pharmacogenetic testing.